CD69 and colorectal carcinoma: Furthermore, T cell activation/exhaustion, as shown by increased CD69 expression, is more pronounced in Tx of HIS mice compared to PF of either PM-CRC or control HIS mice, allowing for anti-CD69 directed immunotherapies to be studied (Figure 4G) (18).